Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells.

Sprenger CC, Drivdahl RH, Woodke LB, Eyman D, Reed MJ, Carter WG, Plymate SR.

Neoplasia. 2008 Dec;10(12):1350-61.

2.

An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer.

Plymate SR, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, Montgomery RB, Ludwig DL, Wu JD.

Clin Cancer Res. 2007 Nov 1;13(21):6429-39.

3.

Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening.

Coe KJ, Jia Y, Ho HK, Rademacher P, Bammler TK, Beyer RP, Farin FM, Woodke L, Plymate SR, Fausto N, Nelson SD.

Chem Res Toxicol. 2007 Sep;20(9):1277-90. Epub 2007 Aug 17.

4.

Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors.

Wu JD, Haugk K, Coleman I, Woodke L, Vessella R, Nelson P, Montgomery RB, Ludwig DL, Plymate SR.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6153-60.

5.

Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.

Thomas PS Jr, Fraley GS, Damian V, Woodke LB, Zapata F, Sopher BL, Plymate SR, La Spada AR.

Hum Mol Genet. 2006 Jul 15;15(14):2225-38. Epub 2006 Jun 13. Erratum in: Hum Mol Genet. 2006 Oct 1;15(19):2972. Damien, Vincent [corrected to Damian, Vincent].

PMID:
16772330
6.

Interaction of IGF signaling and the androgen receptor in prostate cancer progression.

Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.

J Cell Biochem. 2006 Oct 1;99(2):392-401. Review.

PMID:
16639715
7.

Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.

Plymate SR, Tennant MK, Culp SH, Woodke L, Marcelli M, Colman I, Nelson PS, Carroll JM, Roberts CT Jr, Ware JL.

Prostate. 2004 Nov 1;61(3):276-90.

PMID:
15368471

Supplemental Content

Loading ...
Support Center